Syndromic features of JAK1-mediated disease in six affected probandsa
| Proband | P3 | P7 | P9 | P11 | P13 | P16 |
|---|---|---|---|---|---|---|
| Age in years (at time of study) | 14 | 4 | 21 | 7 | 39 | 7 |
| Race/ethnicity (self-reported) | European/French | African American | Ashkenazi Jewish | Ashkenazi Jewish | Mestizo S. American | Ashkenazi Jewish |
| JAK1 variant | c.415C>T; p.E139K | c.1516C>T; p.R506C | c.1516C>T; p.R506C | c.1516C>T; p.R506C | c.2099G>A; p.S700N | c.2953G>A; p.V985I |
| Neonatal/developmental | ||||||
| Recurrent infections | ✓ | − | − | ✓ | ✓ | ✓ |
| Growth deceleration | ✓ | ✓ | − | ✓ | − | − |
| Adverse reactions to vaccines | − | − | − | ✓ | ✓ | − |
| Autoimmunity | ||||||
| Myasthenia gravis | − | − | ✓ | − | − | − |
| Autoimmune hepatitis | − | − | − | − | ✓ | − |
| Autoimmune thrombocytopenia | − | − | − | − | ✓ | − |
| Other autoimmune | ✓ | − | − | − | ✓ | − |
| Atopy (excluding dermatitis) | ||||||
| Food allergy | ✓ | ✓ | − | ✓ | − | ✓ |
| Asthma | ✓ | − | − | ✓ | ✓ | − |
| Allergic rhinitis | − | − | − | − | ✓ | − |
| Colitis (GI inflammation) | ||||||
| IBD | − | ✓ | ✓ | − | − | ✓ |
| Diarrhea/constipation (non-IBD) | ✓ | − | − | ✓ | ✓ | ✓ |
| Eosinophilic esophagitis | − | − | − | − | − | ✓ |
| Dermatitis | ||||||
| Atopic dermatitis | ✓ | ✓ | − | ✓ | − | ✓ |
| Hematologic | ||||||
| Peripheral leukocyte anomaly | − | − | − | − | ✓ | − |
| Peripheral eosinophilia | ✓ | ✓ | − | ✓ | − | ✓ |
| Ig abnormalities | ✓ | ✓ | − | ✓ | ✓ | ✓ |
| Family history (of any category) | ✓ | − | ✓ | ✓ | − | ✓ |
| Neonatal/developmental sum | 2 | 1 | 0 | 3 | 2 | 1 |
| Autoimmunity sum | 1 | 0 | 1 | 0 | 3 | 0 |
| Atopy sum | 2 | 1 | 0 | 2 | 2 | 1 |
| Colitis sum | 1 | 1 | 1 | 1 | 1 | 2 |
| Dermatitis sum | 1 | 1 | 0 | 1 | 0 | 1 |
| Hematologic sum | 2 | 2 | 0 | 2 | 2 | 2 |
| Family history | 1 | 0 | 1 | 1 | 0 | 0 |
| Grand total | 10 | 6 | 3 | 10 | 10 | 7 |
| Proband | P3 | P7 | P9 | P11 | P13 | P16 |
|---|---|---|---|---|---|---|
| Age in years (at time of study) | 14 | 4 | 21 | 7 | 39 | 7 |
| Race/ethnicity (self-reported) | European/French | African American | Ashkenazi Jewish | Ashkenazi Jewish | Mestizo S. American | Ashkenazi Jewish |
| c.415C>T; p.E139K | c.1516C>T; p.R506C | c.1516C>T; p.R506C | c.1516C>T; p.R506C | c.2099G>A; p.S700N | c.2953G>A; p.V985I | |
| Neonatal/developmental | ||||||
| Recurrent infections | ✓ | − | − | ✓ | ✓ | ✓ |
| Growth deceleration | ✓ | ✓ | − | ✓ | − | − |
| Adverse reactions to vaccines | − | − | − | ✓ | ✓ | − |
| Autoimmunity | ||||||
| Myasthenia gravis | − | − | ✓ | − | − | − |
| Autoimmune hepatitis | − | − | − | − | ✓ | − |
| Autoimmune thrombocytopenia | − | − | − | − | ✓ | − |
| Other autoimmune | ✓ | − | − | − | ✓ | − |
| Atopy (excluding dermatitis) | ||||||
| Food allergy | ✓ | ✓ | − | ✓ | − | ✓ |
| Asthma | ✓ | − | − | ✓ | ✓ | − |
| Allergic rhinitis | − | − | − | − | ✓ | − |
| Colitis (GI inflammation) | ||||||
| IBD | − | ✓ | ✓ | − | − | ✓ |
| Diarrhea/constipation (non-IBD) | ✓ | − | − | ✓ | ✓ | ✓ |
| Eosinophilic esophagitis | − | − | − | − | − | ✓ |
| Dermatitis | ||||||
| Atopic dermatitis | ✓ | ✓ | − | ✓ | − | ✓ |
| Hematologic | ||||||
| Peripheral leukocyte anomaly | − | − | − | − | ✓ | − |
| Peripheral eosinophilia | ✓ | ✓ | − | ✓ | − | ✓ |
| Ig abnormalities | ✓ | ✓ | − | ✓ | ✓ | ✓ |
| Family history (of any category) | ✓ | − | ✓ | ✓ | − | ✓ |
| Neonatal/developmental sum | 2 | 1 | 0 | 3 | 2 | 1 |
| Autoimmunity sum | 1 | 0 | 1 | 0 | 3 | 0 |
| Atopy sum | 2 | 1 | 0 | 2 | 2 | 1 |
| Colitis sum | 1 | 1 | 1 | 1 | 1 | 2 |
| Dermatitis sum | 1 | 1 | 0 | 1 | 0 | 1 |
| Hematologic sum | 2 | 2 | 0 | 2 | 2 | 2 |
| Family history | 1 | 0 | 1 | 1 | 0 | 0 |
| Grand total | 10 | 6 | 3 | 10 | 10 | 7 |
Check marks (✓) indicate pertinent positives in medical history. Dashes (−) indicate pertinent negatives in medical history. Results reported in binary terms (yes/no) (i.e., whether or not a sign/symptom was present, not how many times a given sign/symptom was present).
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.